Get App
The development of a COVID-19 vaccine would be great news for all of us and some companies may be especially happy. Here are four shares that may benefit from a vaccine. There's been a growing amount...
Alex Gluyas
Alex Gluyas is a finance journalist at at Eureka Report, with a focus on investing and markets. He has a background writing about the resources and mining industry, having written for the Australian Financial Review and The Age. Alex has studied Digital Communication and Media Multimedia at the University of Oklahoma and Arts, Business, Journalism and Business Management at Monash University. Follow him on LinkedIn.